OmniAb, Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About OmniAb, Inc.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy OmniAb, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for OmniAb, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for OmniAb, Inc. is OABI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
OmniAb, Inc. has its primary listing on NASDAQ. You can trade OmniAb, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, OmniAb, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include OmniAb, Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like OmniAb, Inc. or others.